Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series

Geoffrey Y. Ku, Gilberto De Lima Lopes, Alex Y. Chang

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series'. Together they form a unique fingerprint.

Medicine & Life Sciences